HEADER SIGNALING PROTEIN 26-NOV-18 6N6O TITLE CRYSTAL STRUCTURE OF THE HUMAN TTK IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE,PYT; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE ACTIVITY PROTEIN SERINE/THREONINE/TYROSINE KINASE KEYWDS 2 ACTIVITY ATP BINDING PROTEIN PHOSPHORYLATION MITOTIC CELL CYCLE KEYWDS 3 CHECKPOINT CHROMOSOME SEPARATION, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.FENALTI REVDAT 3 30-OCT-24 6N6O 1 REMARK REVDAT 2 22-MAY-19 6N6O 1 JRNL REVDAT 1 15-MAY-19 6N6O 0 JRNL AUTH J.R.RIGGS,J.ELSNER,D.CASHION,D.ROBINSON,L.TEHRANI,M.NAGY, JRNL AUTH 2 K.E.FULTZ,R.KRISHNA NARLA,X.PENG,T.TRAN,A.KULKARNI, JRNL AUTH 3 S.BAHMANYAR,K.CONDROSKI,B.PAGARIGAN,G.FENALTI,L.LEBRUN, JRNL AUTH 4 K.LEFTHERIS,D.ZHU,J.F.BOYLAN JRNL TITL DESIGN AND OPTIMIZATION LEADING TO AN ORALLY ACTIVE TTK JRNL TITL 2 PROTEIN KINASE INHIBITOR WITH ROBUST SINGLE AGENT EFFICACY. JRNL REF J.MED.CHEM. V. 62 4401 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30998356 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01869 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 11099 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 518 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 806 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 38 REMARK 3 BIN FREE R VALUE : 0.5110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57000 REMARK 3 B22 (A**2) : 0.57000 REMARK 3 B33 (A**2) : -1.85000 REMARK 3 B12 (A**2) : 0.29000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.428 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.274 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.223 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.423 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2051 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1907 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2786 ; 1.746 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4342 ; 1.031 ; 2.991 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 251 ; 6.387 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 80 ;40.728 ;24.875 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 326 ;15.518 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;24.804 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2277 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 440 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6N6O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.2.1 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11650 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 61.843 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.55700 REMARK 200 R SYM FOR SHELL (I) : 0.55700 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: PRISMS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS PH 8.5, 300MM SODIUM REMARK 280 ACETATE, 8% PEG 20K, 8% PEG 500 MME, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.66067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.83033 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.83033 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 81.66067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 513 REMARK 465 HIS A 514 REMARK 465 GLN A 670 REMARK 465 MET A 671 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 VAL A 684 REMARK 465 GLY A 685 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 THR A 795 REMARK 465 LEU A 796 REMARK 465 GLU A 797 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 515 CG OD1 ND2 REMARK 470 GLU A 516 CG CD OE1 OE2 REMARK 470 LYS A 521 CG CD CE NZ REMARK 470 SER A 526 OG REMARK 470 SER A 536 OG REMARK 470 SER A 537 OG REMARK 470 LEU A 543 CD1 CD2 REMARK 470 GLU A 545 CG CD OE1 OE2 REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CE NZ REMARK 470 ILE A 549 CG1 CG2 CD1 REMARK 470 GLU A 558 CG CD OE1 OE2 REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 GLN A 580 CG CD OE1 NE2 REMARK 470 ARG A 587 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 596 CD OE1 NE2 REMARK 470 LYS A 615 CD CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 ILE A 619 CG1 CG2 CD1 REMARK 470 ASP A 620 CG OD1 OD2 REMARK 470 TRP A 622 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 622 CZ3 CH2 REMARK 470 SER A 646 OG REMARK 470 LYS A 649 CD CE NZ REMARK 470 ASP A 657 OD1 OD2 REMARK 470 ASP A 664 OD1 OD2 REMARK 470 ASN A 669 CG OD1 ND2 REMARK 470 THR A 686 OG1 CG2 REMARK 470 LYS A 696 CE NZ REMARK 470 ASP A 697 OD1 OD2 REMARK 470 MET A 698 CG SD CE REMARK 470 SER A 709 OG REMARK 470 LYS A 710 CG CD CE NZ REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 ASN A 739 CG OD1 ND2 REMARK 470 ILE A 741 CG1 CG2 CD1 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 LYS A 762 CG CD CE NZ REMARK 470 LYS A 777 CE NZ REMARK 470 GLN A 794 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 521 48.50 37.29 REMARK 500 SER A 533 -102.97 -122.80 REMARK 500 LYS A 615 -78.37 -64.15 REMARK 500 LYS A 617 -72.13 -78.22 REMARK 500 SER A 646 -21.46 78.47 REMARK 500 ILE A 738 -89.06 -76.01 REMARK 500 ASN A 739 143.60 -39.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KE7 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1PE A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6B4W RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN BOUND TO DIFFERENT INHIBITOR DBREF 6N6O A 515 795 UNP P33981 TTK_HUMAN 515 795 SEQADV 6N6O SER A 513 UNP P33981 EXPRESSION TAG SEQADV 6N6O HIS A 514 UNP P33981 EXPRESSION TAG SEQADV 6N6O LEU A 796 UNP P33981 EXPRESSION TAG SEQADV 6N6O GLU A 797 UNP P33981 EXPRESSION TAG SEQRES 1 A 285 SER HIS ASN GLU CYS ILE SER VAL LYS GLY ARG ILE TYR SEQRES 2 A 285 SER ILE LEU LYS GLN ILE GLY SER GLY GLY SER SER LYS SEQRES 3 A 285 VAL PHE GLN VAL LEU ASN GLU LYS LYS GLN ILE TYR ALA SEQRES 4 A 285 ILE LYS TYR VAL ASN LEU GLU GLU ALA ASP ASN GLN THR SEQRES 5 A 285 LEU ASP SER TYR ARG ASN GLU ILE ALA TYR LEU ASN LYS SEQRES 6 A 285 LEU GLN GLN HIS SER ASP LYS ILE ILE ARG LEU TYR ASP SEQRES 7 A 285 TYR GLU ILE THR ASP GLN TYR ILE TYR MET VAL MET GLU SEQRES 8 A 285 CYS GLY ASN ILE ASP LEU ASN SER TRP LEU LYS LYS LYS SEQRES 9 A 285 LYS SER ILE ASP PRO TRP GLU ARG LYS SER TYR TRP LYS SEQRES 10 A 285 ASN MET LEU GLU ALA VAL HIS THR ILE HIS GLN HIS GLY SEQRES 11 A 285 ILE VAL HIS SER ASP LEU LYS PRO ALA ASN PHE LEU ILE SEQRES 12 A 285 VAL ASP GLY MET LEU LYS LEU ILE ASP PHE GLY ILE ALA SEQRES 13 A 285 ASN GLN MET GLN PRO ASP THR THR SER VAL VAL LYS ASP SEQRES 14 A 285 SER GLN VAL GLY THR VAL ASN TYR MET PRO PRO GLU ALA SEQRES 15 A 285 ILE LYS ASP MET SER SER SER ARG GLU ASN GLY LYS SER SEQRES 16 A 285 LYS SER LYS ILE SER PRO LYS SER ASP VAL TRP SER LEU SEQRES 17 A 285 GLY CYS ILE LEU TYR TYR MET THR TYR GLY LYS THR PRO SEQRES 18 A 285 PHE GLN GLN ILE ILE ASN GLN ILE SER LYS LEU HIS ALA SEQRES 19 A 285 ILE ILE ASP PRO ASN HIS GLU ILE GLU PHE PRO ASP ILE SEQRES 20 A 285 PRO GLU LYS ASP LEU GLN ASP VAL LEU LYS CYS CYS LEU SEQRES 21 A 285 LYS ARG ASP PRO LYS GLN ARG ILE SER ILE PRO GLU LEU SEQRES 22 A 285 LEU ALA HIS PRO TYR VAL GLN ILE GLN THR LEU GLU HET KE7 A 801 38 HET 1PE A 802 16 HET EDO A 803 4 HETNAM KE7 4-({5-CHLORO-4-[(CIS-4-HYDROXY-4-METHYLCYCLOHEXYL)OXY]- HETNAM 2 KE7 7H-PYRROLO[2,3-D]PYRIMIDIN-2-YL}AMINO)-N,N-DIMETHYL-3- HETNAM 3 KE7 {[(2R)-1,1,1-TRIFLUOROPROPAN-2-YL]OXY}BENZAMIDE HETNAM 1PE PENTAETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETSYN 1PE PEG400 HETSYN EDO ETHYLENE GLYCOL FORMUL 2 KE7 C25 H29 CL F3 N5 O4 FORMUL 3 1PE C10 H22 O6 FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *3(H2 O) HELIX 1 AA1 ASP A 561 LEU A 578 1 18 HELIX 2 AA2 LEU A 609 LYS A 616 1 8 HELIX 3 AA3 ASP A 620 HIS A 641 1 22 HELIX 4 AA4 LYS A 649 ALA A 651 5 3 HELIX 5 AA5 PRO A 691 MET A 698 1 8 HELIX 6 AA6 SER A 712 GLY A 730 1 19 HELIX 7 AA7 ASN A 739 ASP A 749 1 11 HELIX 8 AA8 GLU A 761 LEU A 772 1 12 HELIX 9 AA9 SER A 781 ALA A 787 1 7 HELIX 10 AB1 HIS A 788 ILE A 793 1 6 SHEET 1 AA1 6 CYS A 517 VAL A 520 0 SHEET 2 AA1 6 ARG A 523 GLN A 530 -1 O TYR A 525 N ILE A 518 SHEET 3 AA1 6 SER A 537 LEU A 543 -1 O GLN A 541 N LEU A 528 SHEET 4 AA1 6 ILE A 549 ASN A 556 -1 O TYR A 554 N LYS A 538 SHEET 5 AA1 6 TYR A 597 MET A 602 -1 O MET A 602 N ALA A 551 SHEET 6 AA1 6 LEU A 588 ILE A 593 -1 N ASP A 590 O VAL A 601 SHEET 1 AA2 3 ILE A 607 ASP A 608 0 SHEET 2 AA2 3 PHE A 653 ILE A 655 -1 O ILE A 655 N ILE A 607 SHEET 3 AA2 3 LEU A 660 LEU A 662 -1 O LYS A 661 N LEU A 654 SSBOND 1 CYS A 517 CYS A 517 1555 5677 2.50 SITE 1 AC1 12 ILE A 531 GLN A 541 ALA A 551 MET A 602 SITE 2 AC1 12 GLU A 603 GLY A 605 ASN A 606 ILE A 607 SITE 3 AC1 12 ASP A 608 SER A 611 LEU A 654 1PE A 802 SITE 1 AC2 5 LYS A 553 TYR A 568 GLU A 571 MET A 600 SITE 2 AC2 5 KE7 A 801 SITE 1 AC3 4 LYS A 714 GLN A 778 ARG A 779 GLU A 784 CRYST1 71.410 71.410 122.491 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014004 0.008085 0.000000 0.00000 SCALE2 0.000000 0.016170 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008164 0.00000